Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation
In the Netherlands, factor Xa inhibitors are increasingly being selected for OAC-naive AF patients. Seven percent of patients switch to a different OAC within 1 year, and the initial DOAC type and dose are strong predictors of switching.
Authors
- Saskia Middeldorp (ORCID: https://orcid.org/0000-0002-1006-6420)
- Roisin Bavalia (ORCID: https://orcid.org/0000-0002-1806-1050)
- Martin E W Hemels (ORCID: https://orcid.org/0000-0002-2373-9858)
- Menno V. Huisman (ORCID: https://orcid.org/0000-0003-1423-5348)
- Gordon Chu (ORCID: https://orcid.org/0000-0001-5466-3094)
- Hanne van Ballegooijen
- Tim A.C. de Vries (ORCID: https://orcid.org/0000-0003-1392-8193)
- Joris R. de Groot (ORCID: https://orcid.org/0000-0002-8122-7017)
- Helen Xiong
- Kayleigh M van de Wiel
Institutions
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Radboud University Medical Center (NL)
- IQVIA (United Kingdom) (GB)
- Amphia Ziekenhuis (NL)
- Amsterdam University Medical Centers (NL)
- Rijnstate Hospital (NL)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.rpth.2024.102544
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.21